KCM
DTIL icon

Kornitzer Capital Management’s Precision BioSciences DTIL Stock Holding History

Kornitzer Capital Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-6,563
Closed -$2.61M – 496
2019
Q2 		$2.61M Hold
6,563
– – 0.05% 310
2019
Q1 		$3.53M Buy
+6,563
New +$3.48M 0.06% 274

Other funds holding DTIL

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Kornitzer Capital Management's DTIL Position: Q3 2019 in Review

Kornitzer Capital Management sold out of Precision BioSciences (DTIL) in Q3 2019, closing a stake of 6,563 shares — an estimated $2.61M sold.

Kornitzer Capital Management first reported a position in DTIL in Q1 2019 and held it in 2 quarters. The position peaked at $3.53M in Q1 2019. 72 funds tracked by Wall St. Rank hold DTIL as of Q3 2019.

  • Kornitzer Capital Management reported no remaining Precision BioSciences position as of Q3 2019 after selling out during the quarter.
  • Kornitzer Capital Management sold 6,563 Precision BioSciences shares in Q3 2019, an estimated $2.61M.
  • Kornitzer Capital Management first reported a position in Precision BioSciences in Q1 2019 and held it in 2 quarters.
  • Kornitzer Capital Management's Precision BioSciences position peaked at $3.53M in Q1 2019.
  • 72 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2019.

Based on Kornitzer Capital Management's 13F filing for Q3 2019, filed 4 Nov 2019.